The utility of 18F-FDG PET/CT for predicting the pathological response and prognosis to neoadjuvant immunochemotherapy in resectable non-small-cell lung cancer
Metabolic response by <sup>18</sup>F-FDG PET/CT can predict MPR to neoadjuvant immunochemotherapy in resectable NSCLC. ΔMTV% was significantly correlated with PFS.
Authors
- Qing Xie (ORCID: https://orcid.org/0000-0002-4901-4134)
- Huabo Su (ORCID: https://orcid.org/0000-0002-8475-2685)
- Zhi Yang (ORCID: https://orcid.org/0000-0003-2084-5193)
- Xiangxi Meng (ORCID: https://orcid.org/0000-0002-6590-011X)
- Wei Zhao (ORCID: https://orcid.org/0000-0002-8520-2087)
- Wanpu Yan
- Rui Guo (ORCID: https://orcid.org/0000-0003-1096-3487)
- Nan Li (ORCID: https://orcid.org/0009-0003-9012-3898)
- Fei Wang (ORCID: https://orcid.org/0009-0003-1472-5483)
Institutions
- Peking University (CN)
- Peking University Cancer Hospital (CN)
- Ministry of Education (ET)
Publication Details
- Journal
- Cancer Imaging
- Published
- 2024-09-10
- DOI
- https://doi.org/10.1186/s40644-024-00772-x
- Citations
- 11
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 4.61
Funders
- National Natural Science Foundation of China